Apyx Medical Corp Deferred Income Tax Expense (Benefit)
Apyx Medical Corp (APYX) reported Deferred Income Tax Expense (Benefit) of -$4.25 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-03-13
- Apyx Medical Corp deferred income tax expense (benefit) for the quarter ending 2019-12-31 was -$4.73M, a 2418.63% decline year-over-year.
- Apyx Medical Corp deferred income tax expense (benefit) for the quarter ending 2018-12-31 was $204.00K, a 82.71% decline year-over-year.
- Apyx Medical Corp deferred income tax expense (benefit) for the quarter ending 2017-12-31 was $1.18M.
- Apyx Medical Corp deferred income tax expense (benefit) for the quarter ending 2017-03-31 was $0.00.
- Apyx Medical Corp deferred income tax expense (benefit) for fiscal 2024 was -$4.25M.
- Apyx Medical Corp deferred income tax expense (benefit) for fiscal 2023 was -$4.38M.
- Apyx Medical Corp deferred income tax expense (benefit) for fiscal 2022 was -$5.10M.
- Apyx Medical Corp deferred income tax expense (benefit) for fiscal 2021 was -$3.13M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$4.25M 10-K · filed 2025-03-13 | ||||||
| 2023-12-31 | -$4.38M 10-K · filed 2025-03-13 | ||||||
| 2022-12-31 | -$5.10M 10-K · filed 2024-03-21 | ||||||
| 2021-12-31 | -$3.13M 10-K · filed 2023-03-16 | ||||||
| 2020-12-31 | -$1.03M 10-K · filed 2022-03-17 | ||||||
| 2019-12-31 | -$4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$4.73M 10-K · filed 2021-03-31 | |||||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-15 | ||||||
| 2018-12-31 | $204.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | -$164.00K 10-K · filed 2020-03-31 | $87.00K 10-K · filed 2019-03-14 | ||||
| 2018-09-30 | -$368.00K 10-Q/A · filed 2020-05-08 | ||||||
| 2017-12-31 | $1.18M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | $1.18M 10-K · filed 2020-03-31 | -$196.00K 10-K · filed 2018-03-13 | ||||
| 2017-09-30 | $0.00 10-Q/A · filed 2020-05-08 | ||||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | -$2.81M derived: sum of 2 quarters · filed 2019-03-14 | |||||
| 2016-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$2.78M 10-K · filed 2019-03-14 | $25.00K 10-K · filed 2017-03-10 | ||||
| 2016-09-30 | $25.00K 10-Q · filed 2017-11-03 | ||||||
| 2016-03-31 | -$14.00K 10-Q · filed 2017-05-15 | ||||||
| 2015-12-31 | -$25.00K 10-K · filed 2018-03-13 | ||||||
| 2014-12-31 | $3.98M 10-K · filed 2017-03-10 | ||||||
| 2013-12-31 | $1.61M 10-K · filed 2014-03-31 | ||||||
| 2012-12-31 | -$515.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-05-08 | -$420.00K derived: sum of 2 quarters · filed 2014-05-08 | -$351.00K derived: sum of 3 quarters · filed 2014-05-08 | -$217.00K 10-K/A · filed 2014-05-08 | $217.00K 10-K · filed 2013-04-01 | ||
| 2012-09-30 | $95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $164.00K derived: sum of 2 quarters · filed 2012-11-14 | $298.00K 10-Q · filed 2012-11-14 | -$64.00K derived: sum of 4 quarters · filed 2014-05-08 | |||
| 2012-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $203.00K 10-Q · filed 2012-08-14 | -$159.00K derived: sum of 3 quarters · filed 2014-05-08 | -$235.00K derived: sum of 4 quarters · filed 2014-05-08 | |||
| 2012-03-31 | $134.00K 10-Q · filed 2012-05-15 | -$228.00K derived: sum of 2 quarters · filed 2014-05-08 | -$304.00K derived: sum of 3 quarters · filed 2014-05-08 | -$485.00K derived: sum of 4 quarters · filed 2014-05-08 | |||
| 2011-12-31 | -$362.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-05-08 | -$438.00K derived: sum of 2 quarters · filed 2014-05-08 | -$619.00K derived: sum of 3 quarters · filed 2014-05-08 | $77.00K 10-K/A · filed 2014-05-08 | |||
| 2011-09-30 | -$76.00K 10-Q · filed 2011-11-14 | -$257.00K derived: sum of 2 quarters · filed 2011-11-14 | $439.00K 10-Q · filed 2012-11-14 | -$439.00K 10-Q · filed 2011-11-14 | -$1.45M derived: sum of 4 quarters · filed 2013-04-01 | ||
| 2011-06-30 | -$181.00K 10-Q · filed 2011-08-12 | $363.00K 10-Q · filed 2012-08-14 | -$364.00K 10-Q · filed 2011-08-12 | -$1.38M derived: sum of 3 quarters · filed 2013-04-01 | -$1.38M derived: sum of 4 quarters · filed 2013-04-01 | ||
| 2011-03-31 | $182.00K 10-Q · filed 2012-05-15 | -$1.19M derived: sum of 2 quarters · filed 2013-04-01 | -$1.20M derived: sum of 3 quarters · filed 2013-04-01 | -$902.00K derived: sum of 4 quarters · filed 2013-04-01 | |||
| 2010-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | -$1.38M derived: sum of 2 quarters · filed 2013-04-01 | -$1.08M derived: sum of 3 quarters · filed 2013-04-01 | -$934.00K 10-K · filed 2013-04-01 | $934.00K 10-K · filed 2012-03-29 | ||
| 2010-09-30 | -$5.00K 10-Q · filed 2011-11-14 | $292.00K derived: sum of 2 quarters · filed 2011-11-14 | $442.00K 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | $297.00K 10-Q · filed 2011-08-12 | $447.00K 10-Q · filed 2011-08-12 | |||||
| 2009-12-31 | -$60.00K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |